September Newsletter
Golden Helix Recognized as one of the Top 60 Genetics Blogs on the Web

Golden Helix Recognized as one of the Top 60 Genetics Blogs on the Web
By Delaina Hawkins
Director of Marketing

We are incredibly grateful to be recognized as one of the Top 60 Genetics Blogs on the Web by Feedspot. Our team is dedicated to educating our readers on how our solutions can help enable precision medicine, and we are so honored to have received this recognition. On our blog, you will discover posts touching on important topics, like cyber security strategies...

Read More

Cyber Security Strategies for NGS Testing Labs

Cyber Security Strategies for NGS Testing Labs
By Andreas Scherer, PhD
President & CEO

Hospitals and testing labs are undergoing a digital transformation like any other business in our time. They deal with personal data in categories with the highest level of security requirements: personal identity and medical records. The architecture chosen to store and analyze this data is critical to provide the best protection against a data breach incident. The liability and institutional....

Read More

Introducing Drugs & Trials for Cancer Diagnostics

2020 Abstract Competition Winners
By Delaina Hawkins
Director of Marketing

We would like to thank everyone who entered our 2020 Abstract Competition. It is wonderful to read about the different ways Golden Helix software is being applied around the world. It is our pleasure to announce this year’s winners! First Place: Dr. Robert Hamilton and Priyanka Kugamoorthy – SickKids Yearly Clinical Review of a Patient’s WGS Results Leads to a...

Read More

Updated GRCh38 VarSeq Project Templates

Updated GRCh38 VarSeq Project Templates
By Julia Love
Field Application Scientist

As many of our users know, VarSeq comes shipped with various project templates that are designed to give users a baseline workflow to get started with their projects. These templates are tailored for various applications including tumor-normal, trios, cancer and hereditary gene panels, and ACMG Guidelines workflows...

Read More

CEO Corner
New eBook: Clinical Variant Analysis for Cancer

We officially unveiled our new drugs and trials feature of the VSClinical AMP workflow in this month’s webcast. This has been a highly anticipated release for our team and we are looking forward to being able to offer this to our customers. March will be heavily focused on this topic with an upcoming webcast and numerous demos at the ACMG 2020 conference in San Antonio, Texas. If you are planning on attending, please stop by our booth #402 and see this new feature. Additionally, we are very honored to have been recognized as one of the Top 60 Genetics Blogs on the web this month. It goes without saying we could not receive this title without our devoted readers, so thank you! Stay tuned for more exciting news ahead from Golden Helix in the upcoming months!

Upcoming Webcast

A User's Perspective: Drugs & Trials for Cancer Diagnostics
March 4, 2020 | 12:00 PM Eastern

Golden Helix software solutions provide many automated services to streamline variant analysis. This is true when regarding the curation of critical annotations, automation of tertiary project processing via VSPipeline, and of course, the automation of the ACMG and AMP guidelines. Our first iteration when integrating the AMP/ASCO guidelines has added dramatic simplicity and consistency in evaluating biomarkers and provide treatment options via VSReports. Our latest release now includes the automated collection of relevant clinical trials available. 

Register
Customer Success

Congratulations to all of our customers who have published this month! To highlight just a few:

"Six Years’ Experience with LipidSeq: Clinical and Research Learnings from a Hybrid, Targeted Sequencing Panel for Dyslipidemias" - John Robinson & Colleagues, Robarts Research Institute / Published in BMC Medical Genomics 

"Modeling Rectal Cancer to Advance Neoadjuvant Precision Therapy" Medical University of South Carolina / Published in the International Journal of Cancer

About Golden Helix

Golden Helix has been delivering industry-leading bioinformatics solutions for the advancement of life science research and translational medicine for over 20 years with 1,000s of users around the world. Their innovative technologies and analytic services empower scientists and healthcare professionals at all levels to derive meaning from the rapidly increasing volumes of genomic data produced from NGS sequencers and microarrays. With their solutions, hundreds of the world's top hospitals, testing labs, pharmaceutical, biotech, and academic research organizations can harness the full potential of genomics to identify the cause of disease, improve the efficacy and safety of drugs, develop genomic diagnostics, and advance the quest for personalized medicine.